Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Surgery Partners CS (NQ: SGRY )

29.41 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 29.41
Bid (Size) 26.00 (1)
Ask (Size) 46.76 (1)
Prev. Close 29.41
Today's Range 29.41 - 29.41
52wk Range 22.25 - 36.91
Shares Outstanding 82,478,580
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
9 Analysts Assess Surgery Partners: What You Need To Know
Via Benzinga
Here’s Why Surgery Partners Could Be the Next Hot Takeover
Surgery Partners is the third-largest operator of ambulatory surgery centers (ASCs) in the United States, with over 200 locations. 
Via MarketBeat

Performance

YTD
-7.02%
-7.02%
1 Month
-8.78%
-8.78%
3 Month
-3.13%
-3.13%
6 Month
+19.41%
+19.41%
1 Year
+27.15%
+27.15%

More News

Read More
Uncovering Noteworthy Technical Analysis Findings for SURGERY PARTNERS INC (NASDAQ:SGRY).
Via Chartmill
Concentra's Post-IPO Trading Levels Based On 'Its Dominant Market Position,' Says Analyst
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
What 8 Analyst Ratings Have To Say About Surgery Partners
Via Benzinga
Critical Insights From Surgery Partners Analyst Ratings: What You Need To Know
Via Benzinga
Expert Ratings For Surgery Partners
Via Benzinga
Preview: Surgery Partners's Earnings
Via Benzinga
The Latest Analyst Ratings for Surgery Partners
Via Benzinga
SGRY Stock Earnings: Surgery Partners Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Riot Platforms & North Face Parent V.F. Corp Are Among 11 Mid-Cap Stocks That Performed The Best Last Week (July 14-July 20): Are Others In Your Portfolio?
Via Benzinga
SGRY Stock Earnings: Surgery Partners Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Expert Ratings for Surgery Partners
Via Benzinga
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For February 26, 2024
Via Benzinga
Jim Cramer Says It's 'Still Not Too Late' To Buy This Energy Stock
Via Benzinga
Surgery Partners feeling no pinch from macroeconomic weakness
Via MarketBeat
Exposures COVID-19
Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of Directors
From Teladoc Health, Inc.
Via GlobeNewswire
Earnings Scheduled For November 7, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.